CALTON & ASSOCIATES, INC. - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 2 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$3,000
-62.5%
10,000
-16.7%
0.00%
-50.0%
Q3 2021$8,000
-46.7%
12,0000.0%0.00%
-33.3%
Q2 2021$15,000
-6.2%
12,0000.0%0.00%0.0%
Q1 2021$16,000
-5.9%
12,000
-14.3%
0.00%0.0%
Q4 2020$17,000
-43.3%
14,000
-26.3%
0.00%
-50.0%
Q3 2020$30,000
+42.9%
19,000
+11.8%
0.01%
+20.0%
Q2 2020$21,000
+10.5%
17,000
-2.9%
0.01%0.0%
Q1 2020$19,00017,5000.01%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders